Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/18/26 16:06 | 3/2/26 | ALLO | Health | BioPrd | Biological Products, (No Diag | Beneski Benjamin Machinas | CA | O | SVP,Chie | 3 | S.d | -44 | 2.23 | 0 | -20 | 210 | D | |||||||||||||||
3/18/26 16:05 | 3/16/26 | ALLO | Health | BioPrd | Biological Products, (No Diag | Chang David D | CA | DO | P,CEO | 2 | S.d | -289 | 2.02 | 0 | -143 | 8,099 | D | |||||||||||||||
2/4/26 17:16 | 2/2/26 | ALLO | Health | BioPrd | Biological Products, (No Diag | Parker Geoffrey M. | CA | O | CFO | 1 | S.d | -42 | 1.76 | 0 | -24 | 1,253 | D | |||||||||||||||
2/4/26 17:12 | 2/2/26 | ALLO | Health | BioPrd | Biological Products, (No Diag | Douglas Earl Martin | CA | O | SVP,GC | 1 | S.d | -40 | 1.76 | 0 | -23 | 565 | D | |||||||||||||||
2/4/26 17:09 | 2/2/26 | ALLO | Health | BioPrd | Biological Products, (No Diag | Yoshiyama Annie | CA | O | SVP,Fina | 1 | S.d | -7 | 1.72 | 0 | -4 | 130 | D | |||||||||||||||
2/4/26 17:07 | 1/21/26 | ALLO | Health | BioPrd | Biological Products, (No Diag | Roberts Zachary | CA | O | EVP of R | 2 | S.d | -104 | 1.68 | 0 | -62 | 617 | D | |||||||||||||||
12/22/25 18:57 | 12/18/25 | ALLO | Health | BioPrd | Biological Products, (No Diag | Kazam Joshua A | CA | D | 1 | M.d | 0 | 0.00 | 0 | 48 | 16 | 351 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |